Arlington Capital invests in injectable drugs maker Afton Scientific
PE Hub
JANUARY 30, 2024
Tom Thorpe, founder and CEO of Afton, will continue to lead the company and remain a material shareholder going forward. The post Arlington Capital invests in injectable drugs maker Afton Scientific appeared first on PE Hub.
Let's personalize your content